Furthermore, the suppression of AK6 expression has been reported to reduce the migratory ability and EMT of cervical cancer cells under hypoxic conditions, indicating that it may be a potential therapeutic target for cervical cancer [86]. This evidence concerns the gene AK6 and cervical carcinoma.